Study Details
Late Phase 2 Study of Tacrolimus (FK506) for Ulcerative Colitis - A Placebo Controlled, Double-Blind, Comparative Study
Clinicaltrials.gov ID
N/A
Astellas Study ID
FJ-506-UC04
EudraCT ID
N/A
Condition
Ulcerative Colitis
Phase
Phase 2
Age
16 Years - 64 Years
Sex
Female & Male
Product
tacrolimus
Type
Interventional
Trial Dates
Oct 2002 - Sep 2003
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Enrollment number
65
Late Phase 2 Study of Tacrolimus (FK506) for Ulcerative Colitis - A Placebo Controlled, Double-Blind, Comparative Study
Study summary
Study documents
Get More Information
Would you like more information about clinical trial sites that are recruiting participants for Late Phase 2 Study of Tacrolimus (FK506) for Ulcerative Colitis - A Placebo Controlled, Double-Blind, Comparative Study? Contact us by filling our your information to the right and we’ll respond to you.